— Know what they know.
Not Investment Advice

ALEC NASDAQ

Alector, Inc.
1W: -3.9% 1M: -9.8% 3M: +11.1% YTD: +44.4% 1Y: +61.3% 3Y: -71.0% 5Y: -87.0%
$2.21
+0.00 (+0.00%)
 
Weekly Expected Move ±11.8%
$2 $2 $2 $2 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 31 · $245.4M mcap · 78M float · 0.911% daily turnover · Short 56% of daily vol

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$21M -79.1% ▼
5Y CAGR: -0.1%
Gross Profit
$11M -88.7% ▼
Operating Income
-$146M -0.6% ▼
Net Income
-$143M -20.1% ▼
EPS (Diluted)
$-1.39 -13.0% ▼
EBITDA
-$133M +2.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$207M$134M$97M$101M$21M
YoY Growth+881.5%-35.5%-27.4%+3.6%-79.1%
Cost of Revenue$189M$0$9M$0$10M
Gross Profit$18M$134M$88M$101M$11M
Gross Margin8.5%100.0%90.9%100.0%54.1%
R&D Expenses$189M$210M$192M$186M$123M
SG&A Expenses$55M$61M$57M$60M$54M
Operating Expenses$55M$271M$240M$246M$157M
Operating Income-$37M-$138M-$152M-$145M-$146M
Operating Margin-18.0%-103.2%-156.3%-144.2%-692.8%
Interest Expense$0$0$0$0$0
Income Before Tax-$36M-$130M-$125M-$119M-$143M
Tax Expense$0$3M$5M$128K$168K
Net Income-$36M-$133M-$130M-$119M-$143M
Net Margin-17.5%-99.8%-134.3%-118.4%-679.2%
EPS (Diluted)$-0.45$-1.62$-1.56$-1.23$-1.39
EBITDA-$29M-$129M-$143M-$136M-$133M
Shares Outstanding80M82M84M97M103M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms